دورية أكاديمية
Outcome analysis of patients with Peyronie's disease who elect for vacuum erection device therapy.
| العنوان: | Outcome analysis of patients with Peyronie's disease who elect for vacuum erection device therapy. |
|---|---|
| المؤلفون: | MacDonald LP; Department of Urology, Dalhousie University, Halifax, NS, Canada., Armstrong ML; Department of Urology, Dalhousie University, Saint John, NB, Canada., Lehmann KJ; Department of Urology, Dalhousie University, Halifax, NS, Canada., Acker MR; Department of Urology, Dalhousie University, Saint John, NB, Canada., Langille GM; Department of Urology, Dalhousie University, Saint John, NB, Canada. |
| المصدر: | Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2020 Sep; Vol. 14 (9), pp. E428-E431. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Canadian Urological Association Country of Publication: Canada NLM ID: 101312644 Publication Model: Print Cited Medium: Print ISSN: 1911-6470 (Print) Linking ISSN: 19116470 NLM ISO Abbreviation: Can Urol Assoc J Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: Dorval, QC, Canada : Canadian Urological Association Original Publication: Montréal : Canadian Medical Association |
| مستخلص: | Introduction: Peyronie's disease (PD) affects approximately 0.7-11% of men and has numerous proposed treatments. Invasive management options include surgical or injectable therapy, while penile traction therapy with vacuum erection device (VED) represents a non-invasive approach. Our objective is to assess outcomes for patients with PD who opt for non-invasive management. Methods: We performed a retrospective analysis for patients with PD who were followed for at least three months and opted for noninvasive therapy. All patients were instructed to initiate VED traction therapy for 10 minutes twice per day. Patients were assessed for degree of PD deformity and erectile function (Sexual Health Inventory for Men [SHIM] score) at initial and subsequent encounters. Results: Fifty-three patients met the inclusion criteria. The mean (standard deviation [SD]) age was 57 (12) years, and the mean (SD) duration of PD prior to assessment was 25 (15) months. The mean (SD) duration of followup was 14 (11) months. Among untreated patients who did not use a VED, nine showed improvement, 20 remained stable, and four had worsening curvature. The untreated group had a significant change in curvature, with a mean improvement (SD) of 3.6 (12)° (p=0.048). All 20 men who initiated VED traction therapy had an improvement in curvature with a significant mean (SD) improvement of 23 (16)° (p=2.6×10 -6 ). Changes in SHIM scores did vary significantly between groups. No complications were noted. Conclusions: In patients who opt for non-invasive management of PD, VED traction therapy provides improved curvature resolution compared to those who do not use such a device. The limitations of this study include the retrospective nature and a small sample size at a single treatment center. |
| التعليقات: | Comment in: J Urol. 2021 Mar;205(3):912-914. (PMID: 33356458) |
| References: | BJU Int. 2010 Oct;106(8):1178-80. (PMID: 20438558) J Sex Med. 2009 Apr;6(4):903-909. (PMID: 19338644) J Urol. 1999 Apr;161(4):1141-4. (PMID: 10081856) PLoS One. 2016 Feb 23;11(2):e0150157. (PMID: 26907743) J Sex Med. 2008 Apr;5(4):954-964. (PMID: 18042214) BJU Int. 2014 Jan;113(1):133-6. (PMID: 24053665) J Urol. 2015 Sep;194(3):754-8. (PMID: 25804087) Andrology. 2015 Mar;3(2):260-4. (PMID: 25331235) J Sex Med. 2012 Apr;9(4):1182-9. (PMID: 21054791) Eur Urol. 2006 Jun;49(6):987-97. (PMID: 16698449) J Sex Med. 2012 Jan;9(1):288-95. (PMID: 22024053) J Sex Med. 2008 Sep;5(9):2179-84. (PMID: 18638001) Int J Impot Res. 2003 Oct;15 Suppl 5:S93-102. (PMID: 14551585) Int J Impot Res. 2003 Oct;15 Suppl 5:S103-12. (PMID: 14551586) Curr Urol Rep. 2018 May 17;19(7):51. (PMID: 29774446) J Urol. 1997 Jan;157(1):311-5. (PMID: 8976287) BJU Int. 2017 Nov;120(5):717-723. (PMID: 28612401) Prog Urol. 2014 Mar;24(3):203-11. (PMID: 24560211) Int J Impot Res. 2005 Jul-Aug;17(4):307-19. (PMID: 15875061) J Urol. 2015 Sep;194(3):745-53. (PMID: 26066402) J Sex Med. 2008 Aug;5(8):1977-84. (PMID: 18564146) Andrologia. 2018 Sep;50(7):e13051. (PMID: 29806152) Andrology. 2015 Jul;3(4):650-60. (PMID: 26097120) Sex Med Rev. 2019 Apr;7(2):329-337. (PMID: 30503796) J Sex Med. 2017 Oct;14(10):1270-1276. (PMID: 28923308) Ther Adv Urol. 2013 Feb;5(1):59-65. (PMID: 23372611) |
| تواريخ الأحداث: | Date Created: 20200401 Latest Revision: 20211109 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC7492030 |
| DOI: | 10.5489/cuaj.6205 |
| PMID: | 32223874 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1911-6470 |
|---|---|
| DOI: | 10.5489/cuaj.6205 |